Knobbe Martens
Rosaleen Chou is a seasoned legal professional with extensive experience in trademark and copyright law. Currently serving as a Partner and Of Counsel at Knobbe Martens since May 2018, Rosaleen previously held various roles at Kilpatrick Townsend & Stockton LLP, including Associate on the Trademark and Copyright Team for two separate tenures (2008-2010, 2011-2018) and a Full-Time Secondee on the Trademark Team at Facebook from August 2016 to March 2017. Earlier in her career, Rosaleen worked as an Associate Economist in the Public Health and Policy Group at RTI International from 2003 to 2005. Rosaleen Chou holds a Juris Doctor degree from Georgia State University College of Law (2008) and a Bachelor of Arts in Economics from the University of North Carolina at Chapel Hill (2003), having also studied at the University of Cincinnati in 2000-2001.
This person is not in any teams
This person is not in any offices
Knobbe Martens
2 followers
Our firm boasts IP law’s largest and most experienced biotechnology group, with more than 60 attorneys and scientists representing clients in all stages of their business and technology development. Our clients are innovators in a variety of disciplines including PCR, molecular tools and probes, immunology (antibodies and other binding proteins), cell varieties and uses (including stem cells) and biological polymers, to name but a few. Our expertise across the entire biotech landscape gives us great insight into specific technologies, systems and markets. More importantly, our holistic understanding of the interrelated technologies and systems typically involved in a single invention allows us to provide coordinated guidance and counsel from inception though introduction. Working in collaboration with more than 300 IP firms worldwide, we effect patent, trademark, copyright, and other filings, and direct oppositions, cancellations, and litigation matters in over 120 countries. We have considerable experience in negotiating and drafting traditional licensing agreements as well as agreements for strategic alliances, partnerships and joint ventures. We also maintain a talented litigation department adept in all aspects of biotechnology IP law, including the Biosimilars legislation. Our extensive Hatch-Waxman litigation experience combined with our understanding of the biotechnology industry uniquely positions Knobbe Martens to help clients develop and implement litigation strategies designed to maximize their place in the Biosimilars market place. In addition, we have considerable experience litigating before the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission. Our attorneys have experience in all areas of Biotechnology, including: Aesthetic & Cosmetic Biotechnology Antibodies & Immunology Biofuels Biological Manufacturing Of Chemicals Biologics Diagnostic Tools Genomics Industrial Enzymes Peptides Personalized Medicine Research Tools & Reagents Stem Cells & Regenerative Medicine Synthetic Biology & Nanotechnology Therapeutics Tissue Engineering Transgenic Animals Vaccines